E-Test sensitivity and specificity for determination of antimicrobial susceptibility in clinical isolation of Helicobacter pylori

Sensibilidad y especificidad de E-test para la determinación de susceptibilidad antimicrobiana en aislamientos clínicos de Helicobacter pylori

Published 2014-04-21

Open | Download
PDF (Spanish) FLIP HTML (Spanish)
Issue
Vol. 6 No. 10 (2008)
Section
Artículo de Metanálisis
How to Cite
Rey Arévalo et al., M. (2014). E-Test sensitivity and specificity for determination of antimicrobial susceptibility in clinical isolation of Helicobacter pylori. NOVA, 6(10). https://revistas.unicolmayor.edu.co/index.php/nova/article/view/121
DOI
license

Licencia Creative Commons

NOVA by http://www.unicolmayor.edu.co/publicaciones/index.php/nova is distributed under a license creative commons non comertial-atribution-withoutderive 4.0 international.

Furthermore, the authors keep their property intellectual rights over the articles.

 

Marcela Rey Arévalo et al.
    Show authors biography
    Numerous methods have been developed to detect Helicobacter pylori resistance to antimicrobials. The agar dilution is the reference method recommended by the Clinical Laboratory Standards Institute. However, it is not an easy technique that could be implemented at the laboratory routine. It must have sufficient time for preparation and handling of many culture mediums with different antibiotic concentrations. For that reason, several techniques emerge as an alternative of analysis, including E-test: an agar diffusion method, which consists of a strip with an antibiotic concentration gradient, which by reading an ellipse inhibition allows knowing the minimum inhibitory concentrations (MICs). These studies’ operative characteristics were obtained by means of contingency tables. The analysis was done using the program RevMan 5®.   From a total of 68 analyzed references, 8 reached the inclusion criteria. E-test sensitivity and specificity were analyzed as overall summary measures. 87% of the articles showed 100% sensitivity, and 75% showed 100% specificity. The summary measured obtained for sensitivity was 99% (IC 95% 98 – 99%) and 98% specificity (IC95% 97 - 99%). Heterogeneity tests showed homogenous studies in sensitivity and specificity (p = 0.82) (p = 0.99). Funnel Plot graphics showed asymmetry. E-test sensitivity (99%) and specificity (98%) showed excellent agreement, especially for claritromicine; however, there is no significant statistical evidence to conclude that more that 90% of the selected literature reports values of E-test sensitivity and specificity higher than 90% when compared to Agar dilution.

    Article visits 410 | PDF visits 130

    Downloads

    Download data is not yet available.
    1. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet1984;1:1311–1315.
    2. Axon A. Helicobacter pylori: what do we still need to know? J Clin Gastroenterol 2006; 40:15-19.
    3. Malaty HM. Epidemiology of Helicobacter pylori. Best Pract Res Clin Gastroenterol 2007;21:205-214.
    4. Cervantes E. Helicobacter pylori e infecciones asociadas. Rev Fac Med UNAM 2006;49:163-167.
    5. Malfertheiner P, Megraud F, O´Morain C, Bazzoli F, El-Omar E, Graham DY, et al. Current concepts in the management of Helicobacter pylori infection: the Maastricht III, consensus Report. Gut 2007;56:772-781.
    6. Farina N, Kasamatsu E, Samudio M, Moran M, Sanabria R, Laspina F. Susceptibilidad a antibioticos de cepas paraguayas de Helicobacter pylori aisladas de pacientes con enfermedad gastroduodenal, Universidad Nacional de Asuncion, Paraguay, Rev Med Chile 2007;135:1009-1014.
    7. Gerrits MM, van Vliet AH, Kuipers EJ, Kusters. JG. Helicobacter pylori and antimicrobial resistance: molecular mechanisms and clinical implications. Lancet Infect Dis 2006;6:699–709.
    8. Matthew W. Preformance standards for antimicrobial susceptibility testing; eighteenth informational supplement. Pan American Health Organization. 2008. Alarcon T, Baquero M, Domingo D, Lopez-Brea M, Royo G. Diagnostico microbiológico de la infeccion por Helicobacter pylori, Procedimientos en Microbiologia Clinica, Recomendaciones de la Sociedad Espanola de Enfermedades Infecciosas y Microbiologia Clinica. 2004.
    9. Coyle M. Manual de Pruebas de Susceptibilidad Antimicrobiana. Department of Laboratory Medicine and Microbiology. Organizacion panamericana del la salud, University of Washington Edit, Editora Coordinadora. Washington-U.S.A 2000. Capitulo 5.
    10. Piccolomini R, Di Bonaventura G, Catamo G, Carbone F, Neri M. Comparative evaluation of the E test, agar dilution, and broth microdilution for testing susceptibilities of Helicobacter pylori strains to 20 antimicrobial agents. J Clin Microbiol.1997; 35:1842-1846.
    11. Egger. M, Smith GD y Altman DG. Sistematic Reviews in Health Care: Meta-Analysis in Context. Edit. BMJ Publishing Group. Segunda edicion2001; 23- 459.
    12. Beltran O. Revisiones sistematicas de la literatura. Rev Col Gastroenterol 2005; 20: 60-69.
    13. Jaeschke R, Gordon H, Guyatt MD y Sackett DL. Guias para usuarios de la literatura medica, parte A .son validos los resultados del estudio?. Ed. Espana1997. pg. 389-391.
    14. Dersimonian R, Kacker R.. Random-effects model for metaanalysis of clinical trials: An update. Contemp Clin Trials. 2007;28:105-114.
    15. Bermudez. M, Perez. A y Morillo. LE. Apreciacion critica de un articulo que presenta una revision sistematica de la literatura en salud. Programa de actualizacion medica permanente. 2000; 52:2-15.
    16. Best LM, Haldane DJ, Keelan M, Taylor DE, Thomson AB, Loo V, et al. Multilaboratory Comparison of Proficiencies in Susceptibility Testing of Helicobacter pylori and Correlation between Agar Dilution and E Test Methods. Antimicrob Agents Chemother. 2003;47:3138-3144.
    17. Dzierzanowska-Fangrat K, Rozynek E, Jozwiak P, Celińska, Cedro D, Madaliński K, Dzierzanowska D. Primary resistance to clarithromycin in clinical strains of Helicobacter pylori isolated from children in Poland. Int J Antimicrob Agents. 2001;18:387-390.
    18. Khan R, Nahar S, Sultana J, Ahmad MM, Rahman M. T2182C Mutation in 23S rRNA Is Associated with Clarithromycin Resistance in Helicobacter pylori Isolates Obtained in Bangladesh. Antimicrob Agents Chemother. 2004;48:3567-3569.
    19. Megraud F, Lehn N, Lind T, Bayerdorffer E, O‘Morain C, Spiller R, et al. Antimicrobial Susceptibility Testing of Helicobacter pyloriin a Large Multicenter Trial: the MACH 2 Study. Antimicrob Agents Chemother. 1999;43:2747-2752.
    20. Osato MS, Reddy R, Reddy SG, Penland RL, Graham DY. Comparison of the Etest and the NCCLS-approved agar dilution method to detect metronidazole and clarithromycin resistant Helicobacter pylori. Int J Antimicrob Agents. 2001;17:39-44.
    21. Wang WH, Wong BC, Mukhopadhyay AK, Berg DE, Cho CH, Lai KC, et al. High prevalence of Helicobacter pylori infection with dual resistance to metronidazole and clarithromycin in Hong Kong. Aliment Pharmacol Ther. 2000;14:901-910.
    22. Dore MP, Osato MS, Realdi G, Mura I, Graham DY, Sepulveda AR. Amoxycillin tolerance in Helicobacter pylori. J Antimicrob Chemother. 1999;43:47-54.
    23. Clarke M, Oxman AD. editores. Manual de Revisores Cochrane 4.1.6. Actualizacion http://www.cochrane.dk/cochrane/handbook.htm (con acceso el 31 de enero de 2003).
    24. Murray PR, Rosenthal KS, Kobayashi GS, Pfaller MA. Microbiologia Medica. 4 ed. Madrid, Espana: Elsevier; 2002.
    Tutorials

    Autors:

    How send article?

    Evaluator pair

    How to evaluate an article?

    Information

    Keywords

    Google Scholar profile

    Is part of
     
    Más leídos en los últimos 30 días

    Current Issue

    Sistema OJS 3.4.0.5 - Metabiblioteca |